Skip to Main Content

Paper Details

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Nat Med
15
2022
MTT, extracranial solid tumors, gene fusion, gene fusions, patient, patients, pediatric, solid cancer, solid tumors, tumor
Author NameAffiliation
Laura B Corson
Laura B CorsonBroad Institute of MIT and Harvard
Laura B Corson
Rochelle BagatellChildren's Hospital of Philadelphia
Rochelle BagatellUniversity of Pennsylvania School of Medicine
Andrew D CherniackHarvard Medical School
Andrew D CherniackBroad Institute of MIT and Harvard
Andrew D Cherniack
Andrew D CherniackHarvard Medical School
Andrew D Cherniack
Andrew D CherniackBroad Institute of MIT and Harvard
Maegan HardenBroad Institute of MIT and Harvard
Maegan HardenBroad Institute of MIT and Harvard
Niall J LennonBroad Institute of MIT and Harvard
Brian D CromptonHarvard Medical School
Brian D Crompton
Laura E MacConaillHarvard Medical School
Laura E MacConaillBrigham and Women's Hospital
Samuel L VolchenboumUniversity of Chicago
Samuel L VolchenboumUniversity of Chicago
Eliezer M Van AllenHarvard Medical School
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenHarvard Medical School
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute
Steven G DuBoisHarvard Medical School
Steven G DuBois
Katherine A JanewayHarvard Medical School
Katherine A Janeway
  • 1 - 30

Datasets